Literature DB >> 10818102

MEK kinase 2 binds and activates protein kinase C-related kinase 2. Bifurcation of kinase regulatory pathways at the level of an MAPK kinase kinase.

W Sun1, S Vincent, J Settleman, G L Johnson.   

Abstract

MEK kinase 2 (MEKK2) is a 70-kDa protein serine/threonine kinase that has been shown to function as a mitogen-activated protein kinase (MAPK) kinase kinase. MEKK2 has its kinase domain in the COOH-terminal moiety of the protein. The NH(2)-terminal moiety of MEKK2 has no signature motif that would suggest a defined regulatory function. Yeast two-hybrid screening was performed to identify proteins that bind MEKK2. Protein kinase C-related kinase 2 (PRK2) was found to bind MEKK2; PRK2 has been previously shown to bind RhoA and the Src homology 3 domain of Nck. PRK2 did not bind MEKK3, which is closely related to MEKK2. The MEKK2 binding site maps to amino acids 637-660 in PRK2, which is distinct from the binding sites for RhoA and Nck. This sequence is divergent in the closely related kinase PRK1, which did not bind MEKK2. In cells, MEKK2 and PRK2 are co-immunoprecipitated and PRK2 is activated by MEKK2. Similarly, purified recombinant MEKK2 activated PRK2 in vitro. MEKK2 activation of PRK2 is independent of MEKK2 regulation of the c-Jun NH(2)-terminal kinase pathway. MEKK2 activation of PRK2 results in a bifurcation of signaling for the dual control of MAPK pathways and PRK2 regulated responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818102     DOI: 10.1074/jbc.M003148200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence.

Authors:  Melissa W McCoy; Meghan L Marré; Cammie F Lesser; Joan Mecsas
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

2.  MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.

Authors:  T P Garrington; T Ishizuka; P J Papst; K Chayama; S Webb; T Yujiri; W Sun; S Sather; D M Russell; S B Gibson; G Keller; E W Gelfand; G L Johnson
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

3.  Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia.

Authors:  Bettina Thauerer; Stephanie zur Nedden; Gabriele Baier-Bitterlich
Journal:  J Neurochem       Date:  2010-01-28       Impact factor: 5.372

4.  MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.

Authors:  Weiyong Sun; Xudong Wei; Kamala Kesavan; Timothy P Garrington; Ruihua Fan; Junjie Mei; Steven M Anderson; Erwin W Gelfand; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

5.  Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells.

Authors:  Marzenna Blonska; Yun You; Romas Geleziunas; Xin Lin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

6.  MEKK2 kinase association with 14-3-3 protein regulates activation of c-Jun N-terminal kinase.

Authors:  Adi E Matitau; Timothy V Gabor; R Montgomery Gill; Michael P Scheid
Journal:  J Biol Chem       Date:  2013-08-20       Impact factor: 5.157

7.  A rho-binding protein kinase C-like activity is required for the function of protein kinase N in Drosophila development.

Authors:  Martha Betson; Jeffrey Settleman
Journal:  Genetics       Date:  2007-05-16       Impact factor: 4.562

8.  A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.

Authors:  Simona Pavan; Nathalie Meyer-Schaller; Maren Diepenbruck; Ravi Kiran Reddy Kalathur; Meera Saxena; Gerhard Christofori
Journal:  Oncogene       Date:  2018-05-01       Impact factor: 9.867

9.  Protein kinase PKN1 represses Wnt/β-catenin signaling in human melanoma cells.

Authors:  Richard G James; Katherine A Bosch; Rima M Kulikauskas; Peitzu T Yang; Nick C Robin; Rachel A Toroni; Travis L Biechele; Jason D Berndt; Priska D von Haller; Jimmy K Eng; Alejandro Wolf-Yadlin; Andy J Chien; Randall T Moon
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

10.  Cleft lip and palate genetics and application in early embryological development.

Authors:  Wenli Yu; Maria Serrano; Symone San Miguel; L Bruno Ruest; Kathy K H Svoboda
Journal:  Indian J Plast Surg       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.